World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ChiCTR
Last refreshed on: 2 October 2017
Main ID:  ChiCTR-ROC-17012780
Date of registration: 2017-09-24
Prospective Registration: No
Primary sponsor: Second Xiangya Hospital, Central South University
Public title: Serum and Salivary Ferritin and Hepcidin Levels in Patients with Chronic Periodontitis and Type 2 Diabetes Mellitus
Scientific title: Serum and Salivary Ferritin and Hepcidin Levels in Patients with Chronic Periodontitis and Type 2 Diabetes Mellitus
Date of first enrolment: 2017-09-15
Target sample size: type 2 diabetes group:22;chronic periodontitis group:22;type 2 diabetes withchronic periodontitis group:22;control group:22;
Recruitment status: Recruiting
URL:  http://www.chictr.org.cn/showproj.aspx?proj=21633
Study type:  Relative factors research
Study design:  Cohort study  
Phase:  Other
Countries of recruitment
China
Contacts
Name: Yun-Zhi Feng   
Address:  139 Renmin Middle Road, Changsha, Hu'nan, China 410011
Telephone: +86 13574854398
Email: fengyunzhi001@csu.edu.cn
Affiliation:  Second Xiangya Hospital, Central South University
Name: Lin-Na Guo   
Address:  139 Renmin Middle Road, Changsha, Hu'nan, China 410011
Telephone: +86 18075181927
Email: guolinna66@csu.edu.cn
Affiliation:  Second Xiangya Hospital, Central South University
Key inclusion & exclusion criteria
Inclusion criteria: 1. patients with T2DM who were diagnosed with T2DM for > 1 year;
2. no history of receiving professional periodontal treatment during the past 6 months;
3. no use of antibiotics or steroidal and nonsteroidal anti-inflammatory medications during the past 3 weeks; and
4. no treatment with immunosuppressive chemotherapy, no current acute illness, and no ongoing pregnancy or lactation.

Exclusion criteria: with history of receiving professional periodontal treatment during the past 6 months; use of antibiotics or teroidal and nonsteroidal anti-inflammatory medications during the past 3 weeks; and treatment with immunosuppressive hemotherapy, no current acute illness, and no ongoing pregnancy or lactation.

Age minimum: 40
Age maximum: 75
Gender: Both
Health Condition(s) or Problem(s) studied
Chronic Periodontitis and Type 2 Diabetes Mellitus
Intervention(s)
type 2 diabetes group:None;chronic periodontitis group:None;type 2 diabetes withchronic periodontitis group:None;control group:None;
Primary Outcome(s)
ferritin;hepcidin;
Secondary Outcome(s)
Secondary ID(s)
Source(s) of Monetary Support
Central South University
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history